20.500.12556/DiRROS-14591 Neutralizing anti-interferon-[gamma] autoantibodies: an ameliorating factor in COVID-19 infection? SARS-CoV-2 COVID-19 interferon-gamma respiratory distress syndrome nontuberculous mycobacteria macrophage activation syndrome acute respiratory distress syndrome SARS-CoV-2 covid-19 interferon gama sindrom dihalne stiske netuberkulozne mikobakterije sindrom aktivacije makrofago vsindrom akutne dihalne stiske true false true Springer Nature Angleški jezik Ni določen (c)The Author(s) Neznano 2021-11-09 14:56:30 2021-11-09 14:56:30 2022-08-20 03:36:30 0000-00-00 00:00:00 2021 0 Nizozemska 0 Nasl. z nasl. zaslona; "Mark Kacar and Paulina Cortes-Acevedo contributed equally to this work."; Opis vira z dne 5. 11. 2021; str. 1531-1535 iss. 7 Vol. 41 Oct. 2021 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616-097 1573-2592 10.1007/s10875-021-01102-7 83776771 https://link.springer.com/content/pdf/10.1007/s10875-021-01102-7.pdf 1 https://dirros.openscience.si/Dokument.php?lang=slv&id=18627 Univerzitetna klinika za pljučne bolezni in alergijo Golnik 0 0 0